ÇÁ·Î±×·¥

2022³â ´ëÇѼҾư¨¿°ÇÐȸ Ãá°èÇмú´ëȸ


ÀϽÃ: 2022³â 5¿ù 28ÀÏ(Åä)

Àå¼Ò: ÇѾç´ëÇб³ HIT ´ëȸÀǽÇ

´ëÇÑÀÇ»çÇùȸ 5ÆòÁ¡ (*ÇʼöÆòÁ¡ 1ÆòÁ¡, ÀϹÝÆòÁ¡ 4ÆòÁ¡)

°¨¿°°ü¸®¿¬¼ö±³À° 5½Ã°£ ÀÎÁ¤



09:30- µî·Ï
09:55-10:00 °³È¸»ç ÃÖÀºÈ­ ȸÀå
10:00-11:30 ½ÉÆ÷Áö¾ö I. Future Direction of Prevention Against Viral Infections in Children ¼º±Õ°üÀÇ´ë ±è¿¹Áø
10:00-10:30 Recent advances in prevention of RSV in young infants ¼­¿ïÀÇ´ë À±±â¿í
10:30-11:00 Advances in development of Influenza vaccines °í·ÁÀÇ´ë ±èÀ±°æ
11:00-11:30 Prevention strategies for CMV infection ¿ï»êÀÇ´ë ÀÌÁø¾Æ
11:30-12:00 ÃÑȸ  
12:00-13:00 Áᫎ  
13:00-13:40 Ư°­ I
Past, present, and future of mRNA vaccines
ÀüºÏÀÇ´ë Á¶´ë¼±
Andrea Carfi, PhD Moderna
13:40-15:00 Ư°­ II ¼­¿ïÀÇ´ë ÃÖÀºÈ­
13:40-14:20 COVID-19 in children and pregnant women in Japan Kensuke Shoji, MD, PhD
National Center for Child Health and Development
14:20-15:00 Clinical features of COVID-19 in children in Korea ¼­¿ïÀÇ´ë Çѹ̼±
15:00-15:20 ÈÞ½Ä  
15:20-16:50 ½ÉÆ÷Áö¾ö II. Combating COVID-19 in Children (*ÇʼöÆòÁ¡) ºÎ»êÀÇ´ë ¹Ú¼öÀº
15:20-15:50 Issues on COVID-19 vaccines in children: effectiveness, safety and goals °í·ÁÀÇ´ë ÃÖ¿µÁØ
15:50-16:20 Surveillance during the COVID-19 pandemic: modeling and monitoring* °¡ÃµÀÇ´ë Á¤ÀçÈÆ
16:20-16:50 Reflecting on infection control measures in COVID-19: what was necessary and what was not?* ÀÌÈ­ÀÇ´ë Á¶Çý°æ
16:50-17:00 Çмú³í¹®»ó ¹× PIV ¿ì¼ö ½É»çÀ§¿ø»ó ¼ö»ó  
17:00-17:10 Æóȸ»ç ¹Ú¼öÀº ºÎȸÀå
(06654) ¼­¿ï½Ã ¼­Ãʱ¸ È¿·É·Î 55±æ 22 1101È£(¼­Ãʵ¿, ±×¸°ºô¿ÀÇǽºÅÚ) ´ëÇѼҾư¨¿°ÇÐȸ
TEL : 02-3478-1668     FAX : 02-3478-1667     E-mail : kspid@kspid.or.kr
Copyright (c) ´ëÇѼҾư¨¿°ÇÐȸ. All Rights Reserved.